Growth Metrics

Organon (OGN) Capital Expenditures (2020 - 2026)

Organon has reported Capital Expenditures over the past 7 years, most recently at $37.0 million for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 15.62% year-over-year to $37.0 million; the TTM value through Mar 2026 reached $167.0 million, up 3.73%, while the annual FY2025 figure was $162.0 million, 7.43% down from the prior year.
  • Capital Expenditures for Q1 2026 was $37.0 million at Organon, down from $45.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $79.0 million in Q4 2023 and troughed at $32.0 million in Q2 2024.
  • A 5-year average of $48.3 million and a median of $46.0 million in 2023 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 57.78% in 2023 and later tumbled 54.93% in 2024.
  • Year by year, Capital Expenditures stood at $63.0 million in 2022, then grew by 25.4% to $79.0 million in 2023, then crashed by 30.38% to $55.0 million in 2024, then dropped by 18.18% to $45.0 million in 2025, then decreased by 17.78% to $37.0 million in 2026.
  • Business Quant data shows Capital Expenditures for OGN at $37.0 million in Q1 2026, $45.0 million in Q4 2025, and $46.0 million in Q3 2025.